{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:29:47Z","timestamp":1778819387398,"version":"3.51.4"},"update-to":[{"DOI":"10.1371\/journal.pcbi.1012815","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000}}],"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Key Program of the National Natural Science Foundation of China","award":["12331018"],"award-info":[{"award-number":["12331018"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["92374108"],"award-info":[{"award-number":["92374108"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"abstract":"<jats:p>Biological and dynamic mechanisms by which Drug-tolerant persister (DTP) cells contribute to the development of acquired drug resistance have not been fully elucidated. Here, by integrating multidimensional data from drug-treated PC9 cells, we developed a novel multiscale mathematical model from an evolutionary perspective that encompasses epigenetic and cellular population dynamics. By coupling stochastic simulation with quantitative analysis, we identified epigenetic instability as the most prominent kinetic feature related to the emergence of DTP cell subpopulations and the effectiveness of intermittent treatment. Moreover, we revealed the optimal schedule for intermittent treatment, including the optimal area for therapeutic time and drug holidays. By leveraging single-cell RNA-seq data characterizing the drug tolerance of lung cancer, we validated the predictions made by our model and further revealed previously unrecognized biological features of DTP cells, such as cell autophagy and migration, as well as new biomarker genes of therapeutic tolerance. Our work not only provides a paradigm for the integration of multiscale mathematical models with newly emerging genomics data but also improves our understanding of the crucial roles of DTP cells and offers guidance for developing new intermittent treatment strategies against acquired drug resistance in cancer.<\/jats:p>","DOI":"10.1371\/journal.pcbi.1012815","type":"journal-article","created":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T18:41:18Z","timestamp":1739558478000},"page":"e1012815","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Integrating multiscale mathematical modeling and multidimensional data reveals the effects of epigenetic instability on acquired drug resistance in cancer"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2694-9559","authenticated-orcid":true,"given":"Shun","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinzhi","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5294-0764","authenticated-orcid":true,"given":"Xiufen","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5131-0215","authenticated-orcid":true,"given":"Suoqin","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,2,14]]},"reference":[{"issue":"11","key":"pcbi.1012815.ref001","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.3390\/cancers14112613","article-title":"Early steps of resistance to targeted therapies in non-small-cell lung cancer","volume":"14","author":"C Delahaye","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"14","key":"pcbi.1012815.ref002","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1158\/0008-5472.CAN-21-3844","article-title":"Drug-tolerant persister cells in cancer therapy resistance","volume":"82","author":"PK Dhanyamraju","year":"2022","journal-title":"Cancer Res"},{"issue":"1","key":"pcbi.1012815.ref003","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cell.2010.02.027","article-title":"A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations","volume":"141","author":"SV Sharma","year":"2010","journal-title":"Cell"},{"issue":"3","key":"pcbi.1012815.ref004","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.trecan.2022.12.004","article-title":"Addressing the genetic\/nongenetic duality in cancer with systems biology","volume":"9","author":"P Kulkarni","year":"2023","journal-title":"Trends Cancer"},{"issue":"22","key":"pcbi.1012815.ref005","doi-asserted-by":"crossref","first-page":"6429","DOI":"10.1158\/0008-5472.CAN-17-1662","article-title":"Multiscale modeling of inflammation-induced tumorigenesis reveals competing oncogenic and oncoprotective roles for inflammation","volume":"77","author":"Y Guo","year":"2017","journal-title":"Cancer Res"},{"issue":"14","key":"pcbi.1012815.ref006","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1158\/0008-5472.CAN-18-3652","article-title":"Patient-specific tumor growth trajectories determine persistent and resistant cancer cell populations during treatment with targeted therapies","volume":"79","author":"C Grassberger","year":"2019","journal-title":"Cancer Res"},{"issue":"6","key":"pcbi.1012815.ref007","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1158\/0008-5472.CAN-14-2103","article-title":"Emergence of drug tolerance in cancer cell populations: an evolutionary outcome of selection, nongenetic instability, and stress-induced adaptation","volume":"75","author":"RH Chisholm","year":"2015","journal-title":"Cancer Res"},{"issue":"10","key":"pcbi.1012815.ref008","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/s43018-021-00261-1","article-title":"IRS1 phosphorylation underlies the non-stochastic probability of cancer cells to persist during EGFR inhibition therapy","volume":"2","author":"A Jacob Berger","year":"2021","journal-title":"Nat Cancer"},{"issue":"10","key":"pcbi.1012815.ref009","doi-asserted-by":"crossref","first-page":"108101","DOI":"10.1103\/PhysRevLett.129.108101","article-title":"Phenomenological approach to cancer cell persistence","volume":"129","author":"DA Kessler","year":"2022","journal-title":"Phys Rev Lett"},{"issue":"7","key":"pcbi.1012815.ref010","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1111\/cas.13266","article-title":"Glucose metabolism-targeted therapy and withaferin a are effective for epidermal growth factor receptor tyrosine kinase inhibitor-induced drug-tolerant persisters","volume":"108","author":"K Kunimasa","year":"2017","journal-title":"Cancer Sci"},{"issue":"1","key":"pcbi.1012815.ref011","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1038\/s41467-021-21884-z","article-title":"Single-cell transcriptional changes associated with drug tolerance and response to combination therapies in cancer","volume":"12","author":"AF Aissa","year":"2021","journal-title":"Nat Commun"},{"issue":"10","key":"pcbi.1012815.ref012","doi-asserted-by":"crossref","first-page":"E2467","DOI":"10.1073\/pnas.1714723115","article-title":"Fundamental limits on dynamic inference from single-cell snapshots","volume":"115","author":"C Weinreb","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"pcbi.1012815.ref013","doi-asserted-by":"crossref","first-page":"110196","DOI":"10.1016\/j.jtbi.2020.110196","article-title":"A general mathematical framework for understanding the behavior of heterogeneous stem cell regeneration","volume":"492","author":"J Lei","year":"2020","journal-title":"J Theor Biol"},{"issue":"3","key":"pcbi.1012815.ref014","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.devcel.2020.09.029","article-title":"Cellular mechanisms and regulation of quiescence","volume":"55","author":"O Marescal","year":"2020","journal-title":"Dev Cell"},{"issue":"8","key":"pcbi.1012815.ref015","doi-asserted-by":"crossref","first-page":"e1009307","DOI":"10.1371\/journal.pcbi.1009307","article-title":"Epigenetic instability may alter cell state transitions and anticancer drug resistance","volume":"17","author":"A Saini","year":"2021","journal-title":"PLoS Comput Biol"},{"issue":"10","key":"pcbi.1012815.ref016","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.annonc.2023.08.008","article-title":"Treatment of evolving cancers will require dynamic decision support","volume":"34","author":"MAR Strobl","year":"2023","journal-title":"Ann Oncol"},{"issue":"5","key":"pcbi.1012815.ref017","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nbt.4096","article-title":"Integrating single-cell transcriptomic data across different conditions, technologies, and species","volume":"36","author":"A Butler","year":"2018","journal-title":"Nat Biotechnol"},{"issue":"10","key":"pcbi.1012815.ref018","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/s41588-021-00926-8","article-title":"Single-cell multimodal glioma analyses identify epigenetic regulators of cellular plasticity and environmental stress response","volume":"53","author":"KC Johnson","year":"2021","journal-title":"Nat Genet"},{"key":"pcbi.1012815.ref019"},{"issue":"5","key":"pcbi.1012815.ref020","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.3390\/cancers13051118","article-title":"Fighting drug resistance through the targeting of drug-tolerant persister cells","volume":"13","author":"G De Conti","year":"2021","journal-title":"Cancers (Basel)"},{"key":"pcbi.1012815.ref021"},{"issue":"5","key":"pcbi.1012815.ref022","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/s41419-020-2534-9","article-title":"Tumor suppressor death-associated protein kinase 1 inhibits necroptosis by p38 MAPK activation","volume":"11","author":"Y-H Wu","year":"2020","journal-title":"Cell Death Dis"},{"issue":"13","key":"pcbi.1012815.ref023","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1016\/j.jmb.2020.04.016","article-title":"Staufen1 is essential for cell-cycle transitions and cell proliferation via the control of E2F1 expression","volume":"432","author":"M Ghram","year":"2020","journal-title":"J Mol Biol"},{"issue":"4","key":"pcbi.1012815.ref024","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.3892\/or.2017.5486","article-title":"High expression of PINK1 promotes proliferation and chemoresistance of NSCLC","volume":"37","author":"R Zhang","year":"2017","journal-title":"Oncol Rep"},{"issue":"2","key":"pcbi.1012815.ref025","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/sj.bjc.6601906","article-title":"Polymorphisms in prostaglandin synthase 2\/cyclooxygenase 2 (PTGS2\/COX2) and risk of colorectal cancer","volume":"91","author":"DG Cox","year":"2004","journal-title":"Br J Cancer"},{"issue":"22","key":"pcbi.1012815.ref026","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1101\/gad.268185.115","article-title":"Down-regulation of LATS kinases alters p53 to promote cell migration","volume":"29","author":"N Furth","year":"2015","journal-title":"Genes Dev"},{"key":"pcbi.1012815.ref027"},{"issue":"12","key":"pcbi.1012815.ref028","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41389-019-0177-4","article-title":"Long non-coding RNA GAS5 acts as proliferation \u201cbrakes\u201d in CD133+ cells responsible for tumor recurrence","volume":"8","author":"NS Sharma","year":"2019","journal-title":"Oncogenesis"},{"issue":"2","key":"pcbi.1012815.ref029","first-page":"842","article-title":"Identification and verification of PRDX1 as an inflammation marker for colorectal cancer progression","volume":"8","author":"G Chu","year":"2016","journal-title":"Am J Transl Res."},{"issue":"7","key":"pcbi.1012815.ref030","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/01.gim.0000177530.55043.c1","article-title":"NQO1, MPO, and the risk of lung cancer: a HuGE review","volume":"7","author":"C Kiyohara","year":"2005","journal-title":"Genet Med"},{"issue":"11","key":"pcbi.1012815.ref031","doi-asserted-by":"crossref","first-page":"609","DOI":"10.5483\/BMBRep.2015.48.11.190","article-title":"Implications of NQO1 in cancer therapy","volume":"48","author":"E-T Oh","year":"2015","journal-title":"BMB Rep"},{"issue":"7938","key":"pcbi.1012815.ref032","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41586-022-05400-x","article-title":"Liver tumour immune microenvironment subtypes and neutrophil heterogeneity","volume":"612","author":"R Xue","year":"2022","journal-title":"Nature"},{"issue":"6166","key":"pcbi.1012815.ref033","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1126\/science.1241328","article-title":"Targeted therapy resistance mediated by dynamic regulation of extrachromosomal mutant EGFR DNA","volume":"343","author":"DA Nathanson","year":"2014","journal-title":"Science"}],"updated-by":[{"DOI":"10.1371\/journal.pcbi.1012815","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000}}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1012815","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T18:56:35Z","timestamp":1739904995000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1012815"}},"subtitle":[],"editor":[{"given":"Claude","family":"Loverdo","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,2,14]]},"references-count":33,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1012815","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pcbi.1012815","asserted-by":"object"}]},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,14]]}}}